Importantly, the observed γδ T-cell responses from neuroblastoma-derived TIL products were tumor-specific, as indicated by the significantly higher expression of CD137 (P = 0.02) and a trend in increased CD107a expression when compared to responses to autologous non-tumorous tissue digest (Fig 3C and D). The gene discussed is TNFRSF9; the disease is neuroblastoma.